R Nakajima

809 citations
13 papers · 688 indexed · h-index 7
Topics
Yersinia bacterium, plague, ectoparasites research (6 papers)Pharmacological Effects of Natural Compounds (4 papers)Cancer therapeutics and mechanisms (2 papers)
Partner nations
JapanUnited States

In The Last Decade

R Nakajima

12 papers receiving 669 citations

Peers

R Nakajima
Comparison fields: 5 of 46
  • Genetics 561
  • Molecular Biology 322
  • Pharmacology 187
  • Parasitology 186
  • Endocrinology 159
Replace Clarissa Cowan with:
Clarissa Cowan United States
Alexander Rakin Germany
Rima Z. Shaikhutdinova Russia
Lauriane E. Quenee United States
David Gur Israel
Derek Elli United States
Г. М. Титарева Russia
Sheri M. Foltz United States
Marta Biedzka-Sarek Finland
Ralf Schulte Germany
R Nakajima relative to Clarissa Cowan United States Clarissa Cowan's profile →
Citations per field
00.5×1.5×1.8×
Clarissa Cowan · 1×
Citations per year

Countries citing papers authored by R Nakajima

Since Specialization
Citations

This map shows the geographic impact of R Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Nakajima more than expected).

Fields of papers citing papers by R Nakajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Nakajima. The network helps show where R Nakajima may publish in the future.

Co-authorship network of co-authors of R Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of R Nakajima. A scholar is included among the top collaborators of R Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Nakajima. R Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 3
3 170
4 50
5 2
6 154
7 210
8
Preparation of monoclonal antibody to V antigen from Yersinia pestis.
24
9
Interaction of Yersinia pestis with mouse peritoneal macrophages in vitro.
3
10
Chemotherapeutic efficacy of ofloxacin against experimental pneumonia with Pseudomonas aeruginosa in guinea pigs.
1
11
Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice.
20
12
Roles of V antigen in promoting virulence in Yersiniae.
45
13 6

About R Nakajima

R Nakajima is a scholar working on Pharmacology, Molecular Medicine and Genetics, having authored 13 papers that have together received 688 indexed citations. Recurring topics across this work include Yersinia bacterium, plague, ectoparasites research (6 papers), Pharmacological Effects of Natural Compounds (4 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Endocrinology (159 citations), Parasitology (186 citations) and Pharmacology (187 citations). R Nakajima has collaborated with scholars based in Japan and United States. Frequent co-authors include Robert R. Brubaker, Vladimir L. Motin, G. B. Smirnov, R R Brubaker, T Une, M Tanaka, Kenichi Sato, Atsushi Kitamura, Koichiro Sato and Fumiko Hara. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026